Comments on: Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis

Comments on: Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis https://www.worldpharmatoday.com/press-releases/genzymes-once-daily-oral-aubagior-approved-in-australia-for-treatment-of-relapsing-multiple-sclerosis/ Magazine for the C-level Pharma Executives Thu, 22 Nov 2012 03:16:16 +0000 hourly 1 https://wordpress.org/?v=6.9.4